IRF2BP2 and ischemic stroke: The identification of super-enhancer-driven genes, specifically “ARAP3,” and “IRF2BP2,” as potential targets in ischemic stroke aligns with previous studies that highlighted the role of these genes in neuroinflammatory processes and cellular responses to ischemic injury.